Biocon Biologics launches stelara biosimilar YESINTEK in US for autoimmune diseases

Share it

Shares of Biocon Ltd ended at ₹321.30, down by ₹0.75, or 0.23% on the BSE.

Leave a Comment

Your email address will not be published. Required fields are marked *